The Union for International Cancer Control (UICC) and multiple partners are establishing the Access to Oncology Medicines (ATOM) Coalition, a new global partnership to increase access to quality-assured essential cancer medicines in low- and lower middle-income countries (LLMICs) and to help countries develop the capacity for their proper use.
"Pain and suffering from cancer is felt everywhere on earth; we have to work together in order to advance cancer care for all. NCCN is proud to be part of the ATOM Coalition and everything UICC does to improve cancer outcomes worldwide. Our experience
supporting in-country partners –including work on NCCN Framework and NCCN Harmonized Guidelines for Sub-Saharan Africa and the Caribbean – has taught us that clinical practice guidelines can be both instructional and aspirational. Standardised
treatment practices provide governments and providers with a resource to anticipate medication needs, thereby reducing overall costs and improving health outcomes.”
– Robert W. Carlson, MD, Chief Executive Officer, National Comprehensive Cancer Network (NCCN)
To learn more about the new global coalition, click here.
For more information on the ATOM Coalition, including a full list of partners, please visit “The Access to Oncology (ATOM) Coalition”